Direxion Daily ORCL Bull 2X ETFORCU

Orcu is the Direxion Daily ORCL Bull 2X Shares ETF, which is designed to deliver 200% of the daily price return of Oracle Corporation’s common stock, reset every trading day. The fund is not a buy-and-hold instrument; it is a concentrated trading tool that resets each afternoon, so if Oracle’s share price falls today, Orcu falls twice as much before tomorrow’s reset. The instrument is thinly documented in the public domain, with its core mechanics-swap agreements, counterparty exposure, and daily rebalancing-hidden behind a SEC filing number and a Nasdaq listing page rather than a lyrical product story.

The Nasdaq market page for Orcu shows it as an ETF with real-time quotes and volume, but it does not reveal the swap counterparties, the exact swap costs, or the intraday spread you’ll pay when you exit. That opacity is the price of admission for a concentrated daily product; what you see on screen is a price, not a promise. The fund’s expense ratio is 1.15%, a figure you can confirm on the FINRA Fund Analyzer, which also flags the daily reset risk and the fact that this is not a fund for investors who nap overnight. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/orcu)

Orcu’s mandate is simple: amplify Oracle’s daily price movement by 200%. The fund does not hold Oracle shares; it holds swap agreements that deliver the net exposure, and the counterparties to those swaps are not named in the public filings. The SEC EDGAR search for Orcu yields a single fund page with the prospectus, but no breakdown of swap counterparty credit risk or the exact costs embedded in the swap pricing. What you do get is the fund’s legal structure, the expense ratio, and the daily reset language that makes this a short-term trading vehicle, not a long-term holding. (source: SEC EDGAR fund search for ORCU, https://www.sec.gov/edgar/search/#/q=ORCU)

On the FINRA Fund Analyzer, Orcu’s fee structure and risk disclosures are laid out in regulatory language, but the tool cannot tell you how the swaps perform during Oracle’s earnings volatility or whether the counterparty margin calls spike at quarter-end. The analyzer confirms the 1.15% expense ratio and flags the daily leverage decay, but it cannot peer inside the swap book or the liquidity of the underlying Oracle exposure. That is the border between what the regulator shows you and what the fund actually holds. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

If you want to see where Orcu trades, the Nasdaq page is the only public source that gives real-time quotes, volume, and the ETF ticker’s current spread. The chart on Nasdaq is a live feed, not a forecast; it shows the price you can transact at, not the price Oracle will trade at tomorrow. The tool does not reveal the swap costs or the intraday rebalancing drag, so the gap between the screen price and the economic return remains a mystery to anyone without the swap sheet. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/orcu)

What we don’t know is the identity of the swap counterparties, the exact swap pricing terms, the credit ratings of those counterparties, or how the fund behaves during Oracle’s earnings gaps. Those facts sit in private ISDA agreements, not in public filings or regulator tools. Until those details surface, Orcu remains a concentrated trading tool whose inner workings are as visible as a London fog. (source: SEC EDGAR fund search for ORCU, https://www.sec.gov/edgar/search/#/q=ORCU; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)